Platelet transfusion support for dengue patients.
Every year, with a predictability that should make it manageable, India's monsoon brings dengue.
And every year, blood banks across the country — from Delhi to Chennai, from Mumbai to Kolkata — face the same acute platelet crisis. Hospital wards fill with dengue patients whose platelet counts have dropped to dangerous levels. Blood banks send urgent alerts. Families of patients scramble to find donors. And the week-by-week race to keep platelet supplies ahead of demand begins again.
The dengue platelet crisis is the most predictable blood supply emergency in India. It happens every year. It follows the monsoon calendar. And yet it catches blood banks short every time — because platelets, with their five-day shelf life, cannot be stockpiled in advance.
The dengue virus, transmitted through the bite of Aedes aegypti mosquitoes, attacks the body through several mechanisms. Among the most medically dangerous is its effect on platelets — the tiny blood cell fragments responsible for clot formation and stopping bleeding.
In dengue, platelet counts fall through a combination of:
1. Direct bone marrow suppression — the dengue virus infects bone marrow cells, reducing platelet production at the source
2. Immune-mediated platelet destruction — the immune response to dengue generates antibodies that mistakenly target platelets, accelerating their destruction
A healthy person has between 150,000 and 450,000 platelets per microlitre of blood. In severe dengue, this can drop to 10,000 or even lower — a level at which spontaneous internal bleeding becomes a serious risk, particularly in the brain, gastrointestinal tract, and lungs.
A cross-sectional study from Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, covering 718 dengue patients from June 2019 to September 2021, found that 78.1% of dengue cases occurred during the monsoon period (June to September). The mean platelet count at presentation was 132.1 ± 64.7 × 10⁹/L — well below normal — with a subset requiring platelet transfusion.
Not every dengue patient needs a platelet transfusion — and this is an important nuance that affects how blood banks and families think about demand.
Clinical guidelines in India and globally indicate that platelet transfusions are recommended primarily when:
A retrospective study of dengue patients with warning signs at SRM Medical College Hospital (January 2023 to December 2024) categorised 283 patients — with 102 requiring platelet transfusion and 181 managed without. This suggests roughly one in three to four dengue patients with warning signs may need platelet support.
A North India study found that 21.5% of platelet concentrates transfused in dengue patients were considered inappropriate — given to patients whose counts did not actually meet transfusion thresholds. This over-transfusion wastes critical platelet stock at precisely the moment when demand most exceeds supply.
The practical implication: educating both patients and clinicians about appropriate transfusion thresholds is as important as increasing platelet supply.
Platelets have a shelf life of only 5–7 days at 20–24°C, under continuous agitation. There is no way to stockpile them for monsoon. A blood bank cannot collect platelets in May and have them available in August.
This means the platelet supply chain must be continuously replenished throughout dengue season — week after week, for the entire July to October window — to keep pace with patient demand that can triple or quadruple normal levels at peak outbreak periods.
Cities with large Aedes mosquito habitats and dense, stagnant-water-prone housing are hardest hit:
At peak dengue periods, the platelet requests at major hospitals in these cities can exceed 50–100 units per day at a single facility — numbers that individual blood banks struggle to supply independently.
For dengue patients who need platelet transfusion, how the platelets are delivered matters medically.
1. Random Donor Platelets (RDP) — platelets extracted from 5–6 units of whole blood and pooled — are the most common form in Indian blood banks. They expose the patient to multiple donors (increasing alloimmunisation risk), require 5–6 blood donations per therapeutic dose, and may have variable potency.
2. Single Donor Apheresis Platelets (SDP) — collected through a 2-hour apheresis session from one donor — provide a concentrated, consistent dose from a single donor. A study comparing SDP and RDP in dengue management found that patients receiving SDP had faster recovery and shorter hospital stays (5.48 days RDP vs. 3.68 days SDP).
SDP is the clinically superior option for dengue patients — but it requires apheresis machines, trained staff, and a sufficient pool of willing apheresis donors. Building and maintaining this pool before dengue season is the critical task.
Blood banks that handle dengue season well do so through preparation, not reaction:
1. Pre-season apheresis donor recruitment — registering and screening apheresis-eligible donors (weight 55–60 kg, platelet count adequate, no aspirin/ibuprofen) before July so they are immediately available for urgent alerts
2. Year-round platelet donor maintenance — regular apheresis donors who give every 2 weeks throughout the year, not just in response to a dengue outbreak
3. Community awareness — making the connection between monsoon and platelet donation explicit in public communications, so donors register and give before the crisis hits rather than during it
4. Digital alert systems — platforms like TheBloodApp that can broadcast urgent platelet donor alerts to registered SDP donors in a specific city within minutes of a blood bank running low
A frequent question during dengue season is whether foods or supplements can raise platelet counts — papaya leaf extract, kiwi fruit, giloy, and similar claims circulate widely.
The medical reality: there is limited, inconsistent clinical evidence for most natural platelet-boosting remedies. A 2025 clinical trial at a hospital in India is studying papaya leaf extract in paediatric dengue patients — but results remain preliminary.
The standard clinical approach: manage dengue supportively (hydration, fever control, monitoring), transfuse platelets when clinical thresholds are met, and monitor daily. Most dengue patients recover without platelet transfusion if managed correctly.
This means the platelet crisis is somewhat concentrated in the subset of dengue patients with genuinely severe thrombocytopenia — but because dengue affects millions of Indians annually, even a fraction needing transfusion represents enormous platelet demand.
1. Register as a platelet donor now — if you weigh 55 kg or more, have not taken aspirin or ibuprofen recently, and are generally healthy. Registering before dengue season means your details are in the system when the first urgent alerts go out in July.
2. Donate platelets every two weeks — regular apheresis donors who maintain this rhythm throughout the monsoon months are the most valuable donors in India's blood system during this period.
3. Avoid aspirin and ibuprofen before donation — these medications impair platelet function and mean your donation cannot be used. Paracetamol is fine.
4. Spread awareness — the connection between monsoon season, dengue, and platelet donation is not well understood by most people. Sharing what you know — especially in July and August — motivates donors to step forward before the crisis peaks.
Register on TheBloodApp today as a platelet donor. Set your blood type, weight, and location. When dengue season brings urgent platelet requests to hospitals near you, you will be the first person contacted. Your two-hour apheresis session during monsoon may save a dengue patient's life. To find apheresis centres near you, call the number listed in the app.
Sources: PMC — Dengue Monsoon Incidence Study KIMS India 2025 | PMC — Transfusion Support Dengue North India | PMC — SDAP in Dengue Management | PMC — Key Laboratory Markers Severe Dengue 2025 | Cureus — Dengue Platelet Count Prediction Pune 2024 | Aster Hospitals — Platelet Count Dengue | Sankalp India Foundation — Platelet Apheresis
Stay informed, stay inspired — your go-to source for everything about blood donation and impact.
Only 6% of India's blood donors are women — despite women accounting for massive blood demand in obstetrics. Here's why the gender gap exists and what can be done about it.
Every monsoon, dengue sweeps India and platelet counts plummet in thousands of patients. Here's why July to October is the most critical period for platelet donation across India.
India has one of the world's largest haemophilia populations. Here's how donated plasma, cryoprecipitate, and clotting factor concentrates keep haemophilia patients alive — and why voluntary blood donation directly helps.
Be a part of the change — donate safely, stay connected, and help someone in need. Download the app today.
Available on
